Regulus Therapeutics Inc (NASDAQ:RGLS)

0.21
Delayed Data
As of Jan 26
 +0.0033 / +1.60%
Today’s Change
0.19
Today|||52-Week Range
2.32
-33.33%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Papadopoulos Stelios /bg Medicine/
Director
Gift11/30/20212,222,222$0.36$800.0K-44.49%
Hagan Joseph P
President & Chief Executive Officer
Sale2/16/20214,144$1.72$7.1K-88.91%
Hagan Joseph P
President & Chief Executive Officer
Sale2/16/20214,144$1.72$7.1K-88.91%
Hagan Joseph P
President & Chief Executive Officer
Sale5/17/20214,186$0.89$3.7K-76.23%
Aker Christopher
General Counsel & Senior Vice President
Sale2/16/2021828$1.72$1.4K-88.91%
Aker Christopher
General Counsel & Senior Vice President
Sale5/17/2021860$0.89$765.40-76.23%
Hagan Joseph P
President & Chief Executive Officer
Sale4/14/202175,850$0.00$0.00-84.18%